Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Glioblastoma × Saline Solution × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 21 Pain, Postoperative 16 Lung Neoplasms 12 Neoplasms 11 Brain Neoplasms 10 Depression 6 Carcinoma, Hepatocellular 6 Thyroid Neoplasms 5 Prostatic Neoplasms 5 Colonic Neoplasms 5 Stomach Neoplasms 4 Pain 4 Ovarian Neoplasms 4 Leiomyoma 4 Head and Neck Neoplasms 4 Colorectal Neoplasms 4 Anxiety Disorders 4 Supratentorial Neoplasms 3 Rectal Neoplasms 3 Pancreatic Neoplasms 3 Myofibroma 3 Multiple Myeloma 3 Lymphoma 3 Hemorrhage 3 Fatigue 3 Emergence Delirium 3 Delirium 3 Chronic Pain 3 Carcinoma, Non-Small-Cell Lung 3 Agnosia 3

Interventions

Temozolomide 244 Radiotherapy 112 Bevacizumab 94 Magnetic Resonance Spectroscopy 50 Radiation 43 pembrolizumab 29 Irinotecan 27 Lomustine 20 Surgical Procedures, Operative 18 Radiosurgery 18 Nivolumab 17 Carmustine 16 Specimen Handling 15 Erlotinib Hydrochloride 15 Aminolevulinic Acid 15 Radiotherapy, Intensity-Modulated 13 Drug Therapy 12 Chemotherapy, Adjuvant 12 Carboplatin 12 Blood Specimen Collection 12 O(6)-benzylguanine 11 Cyclophosphamide 11 sargramostim 10 Thalidomide 10 Filgrastim 9 Etoposide 9 poly ICLC 8 Sunitinib 8 Imatinib Mesylate 8 Everolimus 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02465268 2025-01-14

ATTAC-II

University of Florida

Phase 2 Completed

175 enrolled 18 charts

Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡